BioMelbourne Network
Progressing BioIndustry
News and Opinions
2010
March
PHASE II CLINICAL TRIAL FOR METABOLIC SYNDROME & NASH COMMENCES IN ISRAEL
29 March 2010, Melbourne and Sydney Australia: Immuron (ASX: IMC) has commenced a Phase II clinical trial of its immunotherapy product for the treatment of Metabolic Syndrome and NASH (Nonalcoholic steatohepatitis). The clinical trial is taking place at the Hadassah Hebrew University Medical Centre in Jerusalem under an agreement between Immuron and Hadasit, the Medical Centre’s commercialisati... read more…
2009
August
Overview of U.S. Patent Law Reform Efforts
Jeffrey S Rothstein -Sidley Austin LLP.
Efforts to overhaul the United States patent system are gaining ground. If the reform effort succeeds, the way you obtain and enforce patents in the U.S. will change significantly.
The U.S. House of Representatives and U.S. Senate are now considering separate patent reform bills (H.R. 1260 and S. 515). To become law, a bill must be approved by both ch... read more…
